# A New Method for Delineation of Epileptic Brian Tissue During Epilepsy Surgery (The HFO Study)

> **NCT02207673** · NA · UNKNOWN · sponsor: **UMC Utrecht** · enrollment: 78 (actual)

## Conditions studied

- Refractory Localization-related Epilepsy

## Interventions

- **PROCEDURE:** Tailoring of the resection based on biomarker in aEcoG during epilepsy surgery

## Key facts

- **NCT ID:** NCT02207673
- **Lead sponsor:** UMC Utrecht
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2014-11
- **Primary completion:** 2021-02
- **Final completion:** 2021-06
- **Target enrollment:** 78 (ACTUAL)
- **Last updated:** 2020-11-04

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02207673

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02207673, "A New Method for Delineation of Epileptic Brian Tissue During Epilepsy Surgery (The HFO Study)". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT02207673. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*